Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Ross McFall

Thoracic Surgery (Cardiothoracic Vascular Surgery) Lubbock, TX Medical Doctor

NPI 1609303171 CMS profile 3615958

3514 21St St, Lubbock, TX 79410

Open in the dashboard

General payments

$16,181

237 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Ross McFall of Lubbock, TX is reported in the CMS Open Payments database as having received $16,181 across 237 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 76th percentile of Thoracic Surgery (Cardiothoracic Vascular Surgery) profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $3,074 42
2024 General $1,998 21
2023 General $2,071 15
2022 General $3,293 51
2021 General $2,633 57
2020 General $1,475 24
2019 General $1,636 27

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Ross McFall
  • Thoracic Surgery (Cardiothoracic Vascular Surgery) median
  • Middle half of Thoracic Surgery (Cardiothoracic Vascular Surgery)
  • National median

In program year 2025, general payments to Ross McFall were reported at $3,074. Among 4,073 Thoracic Surgery (Cardiothoracic Vascular Surgery) profiles paid that year, the median was $791 and the middle half received between $208 and $3,074.

Show as a table
Year Ross McFall Thoracic Surgery (Cardiothoracic Vascular Surgery) median Middle half National median
2019 $1,636 $886 $178–$3,167 $163
2020 $1,475 $341 $108–$1,605 $114
2021 $2,633 $453 $125–$1,886 $132
2022 $3,293 $695 $180–$2,566 $149
2023 $2,071 $745 $205–$2,662 $160
2024 $1,998 $799 $214–$2,967 $164
2025 $3,074 $791 $208–$3,074 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Medtronic, Inc. $3,335 42 payments
  2. W. L. Gore & Associates, Inc. $2,813 51 payments
  3. Medical Device Business Services, Inc. $1,856 6 payments
  4. Cook Medical LLC $1,192 23 payments
  5. Silk Road Medical, Inc. $1,147 15 payments
  6. CryoLife, Inc. $997 8 payments
  7. Inari Medical, Inc. $841 11 payments
  8. Baxter Healthcare $592 9 payments
  9. Edwards Lifesciences Corporation $410 2 payments
  10. Medtronic Vascular, Inc. $308 5 payments
  11. Other $2,691 65 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Food and Beverage $11,365 213 payments
  2. Travel and Lodging $4,073 21 payments
  3. Education $744 3 payments
Products named General payments · program years 2019–2025
  1. SYNFIX Evolution $1,823 5 payments
  2. ENDURANT IIS $1,397 15 payments
  3. COREVALVE EVOLUT R $1,110 11 payments
  4. ENROUTE Transcarotid Stent $1,019 14 payments
  5. ENROUTE Transcarotid Neuroprotection System $1,019 14 payments
  6. Cardiac non-SynerGraft $997 8 payments
  7. GORE VIABAHN VBX Balloon Expandable Endo $791 13 payments
  8. FLOWTRIEVER CATHETER, S $634 9 payments
  9. ENHANCE Transcarotid Peripheral Access Kit $476 6 payments
  10. ENROUTE .014 Guidewire $476 6 payments
  11. Other $9,801 169 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Billing to Medicare

Part B · data year 2024 · 50 billing codes

Paid by Medicare

$31,336

Medicare's payments for the services billed

Medicare patients

42

Average age 74

Services billed

118

17 women, 25 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Ischemic heart disease 75%
Chronic kidney disease 55%
Diabetes 50%
Arthritis 45%
Heart failure 43%
Atrial fibrillation 36%
COPD 31%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

237 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Thoracic Surgery (Cardiothoracic Vascular Surgery) in Texas

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record